Federal Reserve meeting minutes: Almost all participants believe inflation risks are tilted to the upside

According to information from Zhihu Finance APP, AstraZeneca (AZN.US) and Daiichi Sankyo (DSNKY.US) have announced that Datroway® (generic name: datopotamab deruxtecan for injection) has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (TNBC) who are not suitable for PD-1/PD-L1 inhibitor therapies. Datopotamab deruxtecan is an antibody-drug conjugate (ADC) targeting TROP2, developed with proprietary technology by Daiichi Sankyo, and jointly developed and commercialized by AstraZeneca and Daiichi Sankyo.

Trader: Abu Dhabi National Oil Company issued a tender this week to sell crude oil for December loading or January delivery.

The Central Bank of Turkey conducted a one-week gold-for-lira sell swap auction using traditional methods, with a scale of 6 tons.

On October 8 local time, the European Court of Auditors (ECA) released its 2025 annual report, expressing concerns over the continuous growth of EU debt. According to the report, by the end of 2025, the EU's debt had reached approximately 740 billion euros. The report also warns that this figure may further rise to 1 trillion euros by 2027. The ECA pointed out that the increase in EU debt is mainly related to aid for Ukraine, rising interest rates, defense spending, and the EU recovery fund. (CCTV)